Helmholtz Gemeinschaft

Search
Browse
Statistics
Feeds

Identification of early neurodegenerative pathways in progressive multiple sclerosis

[thumbnail of Accepted Manuscript (final draft)]
Preview
PDF (Accepted Manuscript (final draft)) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
88MB
[thumbnail of Supplemental Information] Other (Supplemental Information)
23MB

Item Type:Article
Title:Identification of early neurodegenerative pathways in progressive multiple sclerosis
Creators Name:Kaufmann, M., Schaupp, A.L., Sun, R., Coscia, F., Dendrou, C.A., Cortes, A., Kaur, G., Evans, H.G., Mollbrink, A., Navarro, J.F., Sonner, J.K., Mayer, C., DeLuca, G.C., Lundeberg, J., Matthews, P.M., Attfield, K.E., Friese, M.A., Mann, M. and Fugger, L.
Abstract:Progressive multiple sclerosis (MS) is characterized by unrelenting neurodegeneration, which causes cumulative disability and is refractory to current treatments. Drug development to prevent disease progression is an urgent clinical need yet is constrained by an incomplete understanding of its complex pathogenesis. Using spatial transcriptomics and proteomics on fresh-frozen human MS brain tissue, we identified multicellular mechanisms of progressive MS pathogenesis and traced their origin in relation to spatially distributed stages of neurodegeneration. By resolving ligand-receptor interactions in local microenvironments, we discovered defunct trophic and anti-inflammatory intercellular communications within areas of early neuronal decline. Proteins associated with neuronal damage in patient samples showed mechanistic concordance with published in vivo knockdown and central nervous system (CNS) disease models, supporting their causal role and value as potential therapeutic targets in progressive MS. Our findings provide a new framework for drug development strategies, rooted in an understanding of the complex cellular and signaling dynamics in human diseased tissue that facilitate this debilitating disease.
Keywords:Autoimmunity, Multiple Sclerosis, Neuroimmunology
Source:Nature Neuroscience
ISSN:1097-6256
Publisher:Nature Publishing Group
Volume:25
Number:7
Page Range:944-955
Date:July 2022
Additional Information:Copyright © The Author(s), under exclusive licence to Springer Nature America, Inc. 2022
Official Publication:https://doi.org/10.1038/s41593-022-01097-3
PubMed:View item in PubMed

Repository Staff Only: item control page

Downloads

Downloads per month over past year

Open Access
MDC Library